Human Papillomavirus Infection
📧 Sign up to get email alerts when something new happens for Human Papillomavirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
Completed clinical trial evaluating the effectiveness of a community obstetrics/gynecology vaccination program for influenza, HPV infection,…
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study [Phase 3]
This document reports the results of an extension Phase 3 study evaluating the efficacy of the GSK 580299 HPV vaccine in Japanese women who …
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers [Phase 4]
Phase 4 trial evaluating acceptability of HPV vaccination among female sex workers; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia [Phase 2]
Phase 2 trial evaluating green tea extract for prevention of cervical cancer in patients with HPV infection and low-grade cervical intraepit…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection
This completed clinical trial update compares sexual behavior between oropharyngeal cancer patients and other head and neck cancer patients,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt
This is a completed observational epidemiological study sponsored by GlaxoSmithKline that examines the prevalence of different human papillo…
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System
This document reports the completed clinical evaluation of the Aptima HPV Assay on the PANTHER System. It covers the performance assessment …
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects [Phase 3]
A Phase 3 trial update reporting on the efficacy, immunogenicity, and safety of GSK's HPV vaccine (GSK 580299) in healthy Chinese female sub…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection [Phase 4]
Phase 4 trial results indicate that polyhexamethylene biguanide increases regression of HPV infection.
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females [Phase 2]
Phase 2 trial assessing safety and immunogenicity of Cervarix (HPV vaccine) in HIV-infected females has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-01-25Clinical Trial Update: Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
A completed clinical trial at Barretos Cancer Hospital evaluated HPV vaccination for human papillomavirus infection; the study status is com…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults [Phase 3]
A Phase 3 clinical trial update assessing the long-term immunogenicity of Gardasil in HIV-infected adolescents and young adults.
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)
A completed observational surveillance study of Gardasil (V501-031) to detect potential safety signals after vaccination, with results poste…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females
This clinical trial update reports safety results for a vaccine against cervical cancer tested in healthy Korean women; results were posted …
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil [Phase 2]
This is a Phase 2 follow-up study assessing the long-term efficacy of the HPV vaccine in healthy young adult women in Brazil, with results p…
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects. [Phase 3]
Phase 3 safety study of GlaxoSmithKline's HPV vaccine (GSK-580299) in healthy female subjects, with results posted.
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results
Clinical trial update evaluating the APTIMA HPV 16/18/45 genotype assay on the TIGRIS DTS system in women with ASC-US or negative Pap test r…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) [Phase 2, Phase 3]
An update on a randomized Phase 2/3 trial evaluating vaginal self-sampling for human papillomavirus (HPV) detection.
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) [Phase 1]
Phase 1 dose-escalation study of Merck's Broad Spectrum HPV Vaccine (V502-002) completed. Results were posted in 2011 and evaluated safety a…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects [Phase 3]
Phase 3 trial update on long-term immunogenicity and safety of an HPV vaccine in healthy females with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age. [Phase 3]
Phase 3 immunogenicity and safety update for GSK's HPV vaccine (GSK580299) in healthy females aged 10-25; trial completed with results poste…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Study With Candida Antigen for Treatment of Warts [Phase 1]
A Phase 1 study evaluating Candida antigen as a treatment for warts associated with HPV; the trial completed and posted results in 2011.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED) [Phase 3]
Merck completed the Phase 3 HPV vaccination registration study (Gardasil, V501-023) with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of HPV vaccine co-administered with another vaccine in healthy female subjects; completed…
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age [Phase 3]
Phase 3 trial update comparing GSK HPV vaccine immunogenicity to Merck's Gardasil in healthy women 18-45, with completed status and results …